نتائج البحث - Danielle Charpentier

  • يعرض 1 - 6 نتائج من 6
تنقيح النتائج
  1. 1
    Valuing Alternative Work Arrangements

    Valuing Alternative Work Arrangements حسب Alexandre Mas, Keesler Welch, Danielle Charpentier

    منشور في 2016
    احصل على النص الكامل
    Conjunto de Dados
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada – Clinical Trials Group (NCIC-CTG)

    Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada – Clinical Trials Group (NCIC-CTG) حسب Maureen Trudeau, Michael Crump, Danielle Charpentier, Louise Yelle, Louise Bordeleau, S. Matthews, Elizabeth A. Eisenhauer

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Phase I study of Aplidine in a daily×5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115

    Phase I study of Aplidine in a daily×5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical... حسب J. Maroun, K. Bélanger, Lesley Seymour, S. Matthews, James Roach, Jeanne Dionne, Denis Soulières, David J. Stewart, Rakesh Goel, Danielle Charpentier, Glenwood Goss, Eva Tomiak, J. Yau, José Jimeno, G. Chiritescu

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma

    Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma حسب Houda Bahig, F. Aubin, John Stagg, Olguta Gologan, Olivier Ballivy, Éric Bissada, Felix‐Phuc Nguyen‐Tan, Denis Soulières, Louis Guertin, Édith Filion, Apostolos Christopoulos, Louise Lambert, Mustapha Tehfé, Tareck Ayad, Danielle Charpentier, Rahima Jamal, Philip Wong

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Health-Related Quality of Life in Patients With Advanced Colorectal Cancer Treated With Cetuximab: Overall and <i>KRAS</i>-Specific Results of the NCIC CTG and AGITG CO.17 Trial

    Health-Related Quality of Life in Patients With Advanced Colorectal Cancer Treated With Cetuximab: Overall and <i>KRAS</i>-Specific Results of the NCIC CTG and AGITG CO.17 Trial حسب Heather‐Jane Au, Christos S. Karapetis, Chris J. O’Callaghan, Dongsheng Tu, Malcolm J. Moore, John Zalcberg, Hagen Kennecke, Jeremy Shapiro, Sheryl Koski, Nick Pavlakis, Danielle Charpentier, David Wyld, Michael Jefford, Gregory Knight, Nadine M Magoski, Michael Brundage, Derek J. Jonker

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Phase III Randomized, Placebo-Controlled Study of Cetuximab Plus Brivanib Alaninate Versus Cetuximab Plus Placebo in Patients With Metastatic, Chemotherapy-Refractory, Wild-Type <i>K-RAS</i> Colorectal Carcinoma: The NCIC Clinical Trials Group and AGITG CO.20 Trial

    Phase III Randomized, Placebo-Controlled Study of Cetuximab Plus Brivanib Alaninate Versus Cetuximab Plus Placebo in Patients With Metastatic, Chemotherapy-Refractory, Wild-Type <i... حسب Lillian L. Siu, Jeremy Shapiro, Derek J. Jonker, Christos S. Karapetis, John Zalcberg, John Simes, Félix Couture, Malcolm J. Moore, Timothy Price, Jehan Siddiqui, Louise Nott, Danielle Charpentier, Winston Liauw, Michael B. Sawyer, Michael Jefford, Nadine M Magoski, Andrew Haydon, Ian Walters, Jolie Ringash, Dongsheng Tu, Chris J. O’Callaghan

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: